Lee & Man Chemical Company Limited

HKEX:0746.HK

3.37 (HKD) • At close September 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q32012 Q22011 Q42011 Q22010 Q42010 Q22009 Q42008 Q4
Revenue 1,989.692,054.4451,996.1362,616.2793,250.7582,914.4422,271.51,717.9711,381.7141,757.9151,718.6561,923.531,953.2471,721.1561,252.5911,003.745810.106911.076794.803826.955733.073740.322588.8090314.7830000000
Cost of Revenue 1,414.4761,433.2581,555.1521,934.1421,809.3541,593.6021,253.4161,029.839938.3141,053.8941,036.5631,060.7231,000.828855.061719.509642.392513.501534.01496.697429.737476.364436.61418.6140208.5190000000
Gross Profit 575.214621.187440.984682.1371,441.4041,320.841,018.084688.132443.4704.021682.093862.807952.419866.095533.082361.353296.605377.066298.106397.218256.709303.712170.1950106.2640000000
Gross Profit Ratio 0.2890.3020.2210.2610.4430.4530.4480.4010.3210.40.3970.4490.4880.5030.4260.360.3660.4140.3750.480.350.410.28900.3380000000
Reseach & Development Expenses 54.52948.90171.8583.967120.039136.75194.13794.3859.40967.23671.30284.50677.06481.31845.33423.98421.18541.39236.4483.904062.35216.26808.2910000000
General & Administrative Expenses 135.001130.557128.143122.068154.856163.295136.07124.81898.498129.27583.813120.561105.312111.17281.38665.77266.94557.40458.59860.54249.44942.44461.67606.9640000000
Selling & Marketing Expenses 107.703100.431109.002132.45121.922118.673114.444110.04691.172108.477106.511122.658108.787107.33374.47169.09758.17154.21543.30536.23632.24434.15626.798014.6210000000
SG&A 242.704230.988237.145254.518276.778281.968250.514234.864189.67237.752190.324243.219214.099218.505155.857134.869125.11675.179138.34370.293108.17876.688.474021.5840000000
Other Expenses 00000000000000000000000000000000
Operating Expenses 297.233279.889308.995338.485396.817418.719344.651329.244249.079304.988261.626329.886241.932212.789178.865172.886124.484225.2391.593170.24472.383110.4764.127018.8780000000
Operating Income 277.981341.298131.989343.6521,044.587902.121673.433358.888194.321399.033420.467538.647661.256567.899331.891202.5150.304225.261159.763243.021148.531149.71981.721058.9630000000
Operating Income Ratio 0.140.1660.0660.1310.3210.310.2960.2090.1410.2270.2450.280.3390.330.2650.2020.1860.2470.2010.2940.2030.2020.13900.1870000000
Total Other Income Expenses Net 17.89321.105-1.0376.632.9386.1230.65286.575-2.988-11.01142.396-50.617.6444.556-13.385-28.93416.08-75.12946.049-17.65137.56949.21294.305032.8780000000
Income Before Tax 295.874362.403130.952350.2821,047.525908.241704.085445.463191.333388.022462.863488.037668.896612.455318.506173.566166.384150.132205.812225.37186.1198.931176.026091.8410000000
Income Before Tax Ratio 0.1490.1760.0660.1340.3220.3120.310.2590.1380.2210.2690.2540.3420.3560.2540.1730.2050.1650.2590.2730.2540.2690.29900.2920000000
Income Tax Expense 57.69167.33425.89985.377155.967206.306116.76690.2435.23488.46161.683160.441124.117150.91677.02476.62147.13443.56742.69946.73234.62740.35425.871010.920000000
Net Income 240.085296.054104.611265.446891.329700.981587.028346.415156.213299.591401.18327.287545.354461.571241.48296.945119.25106.565163.113178.638151.473158.577150.155080.9210000000
Net Income Ratio 0.1210.1440.0520.1010.2740.2410.2580.2020.1130.170.2330.170.2790.2680.1930.0970.1470.1170.2050.2160.2070.2140.25500.2570000000
EPS 0.290.360.130.321.080.850.710.420.190.360.490.40.640.560.290.120.140.130.20.220.180.190.1800.0980000000
EPS Diluted 0.290.360.120.311.030.80.710.420.190.360.490.40.640.560.290.120.140.130.20.220.180.190.1800.0980000000
EBITDA 477.572370.511333.36382.1551,082.985931.296701.279386.123218.261427.691438.561393.658846.047459.397473.885141.35237.979161.826251.42323.65225.384212.43139.618087.1720000000
EBITDA Ratio 0.240.180.1670.1460.3330.320.3090.2250.1580.2430.2550.2050.4330.2670.3780.1410.2940.1780.3160.3910.3070.2870.23700.2770000000